Your browser doesn't support javascript.
Rebound of SARS-CoV-2 Infection after Nirmatrelvir-Ritonavir Treatment.
Charness, Michael E; Gupta, Kalpana; Stack, Gary; Strymish, Judith; Adams, Eleanor; Lindy, David C; Mohri, Hiroshi; Ho, David D.
  • Charness ME; VA Boston Healthcare System, West Roxbury, MA michael.charness@va.gov.
  • Gupta K; VA Boston Healthcare System, West Roxbury, MA michael.charness@va.gov.
  • Stack G; VA Connecticut Healthcare System, West Haven, CT.
  • Strymish J; VA Boston Healthcare System, West Roxbury, MA.
  • Adams E; National Basketball Association, New York, NY.
  • Lindy DC; Columbia University Vagelos College of Physicians and Surgeons, New York, NY dh2994@cumc.columbia.edu.
  • Mohri H; Columbia University Vagelos College of Physicians and Surgeons, New York, NY dh2994@cumc.columbia.edu.
  • Ho DD; Columbia University Vagelos College of Physicians and Surgeons, New York, NY dh2994@cumc.columbia.edu.
N Engl J Med ; 387(11): 1045-1047, 2022 09 15.
Article in English | MEDLINE | ID: covidwho-2016955
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Proline / Ritonavir / COVID-19 Drug Treatment / Lactams / Leucine / Nitriles Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2206449

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Proline / Ritonavir / COVID-19 Drug Treatment / Lactams / Leucine / Nitriles Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2206449